Exclusive Online Content
Sanara MedTech Inc. Announces Exclusive License Agreement for Patented Collagen Peptides
Sanara MedTech Inc. recently announced it has signed an exclusive license agreement with Tufts University to develop and commercialize patented technology covering 18 unique….
Natco Pharma Limited Completes Transition of DASH Pharmaceuticals Into Natco Pharma USA, Furthering Strategic Presence in the US
Natco Pharma Limited recently announced DASH Pharmaceuticals, a company that markets, sells, and distributes generic pharmaceutical products, has officially transitioned to….
Sever Pharma Solutions Secures DEA License for Controlled Substances Handling in Putnam, CT
Sever Pharma Solutions recently announced the successful attainment of the Drug Enforcement Administration (DEA) license for its site in Putnam, CT. This license, effective as….
Abzena Partners With FDA on MAPPs Assay Publication
Abzena has recently co-authored a publication with the US FDA demonstrating the potential of the MHC Associated Peptide Proteomics (MAPPs) assay as an important method to interrogate immunogenicity risk….
Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress & Key Milestones Accomplished
Lipella Pharmaceuticals Inc. recently celebrated its first anniversary as a publicly traded entity. Based in Pittsburgh, PA, the company has made substantial strides over the past year, achieving critical milestones….
Successful Transfer of NDA Acknowledged by FDA From Former Zosano Pharma to Emergex for Investigational Microneedle-Based Drug Delivery Patch
Emergex Vaccines Holding Limited recently announced the company has transferred ownership, as of May 2023, of the existing US FDA New Drug Application (NDA) of the investigational MAP originally intended….
POINT Biopharma & Lantheus Announce Positive Topline Results From Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate Cancer
POINT Biopharma Global Inc. and Lantheus Holdings, Inc. recently announced statistically significant topline results from the pivotal….
Global Confidence in Drug Delivery Innovation Remains at Record Highs According to Pharmapack
The annual Pharmapack Drug Delivery Innovation Index is released ahead of Europe’s premier drug delivery and packaging event, Pharmapack Europe 2024 (January 24-25) – held at the Paris Expo, Porte de Versailles (Hall 7.2). The results showed….
Roche Completes Acquisition of Telavant From Roivant, Including Rights to Novel TL1A Directed Antibody for Inflammatory Bowel Disease Treatment
Roivant recently announced the completion of the previously announced acquisition by Roche of Telavant, for an upfront payment of approximately $7.1 billion…..
Aeterna Zentaris & Ceapro Announce Merger to Create Diversified Biopharmaceutical Company
Aeterna Zentaris Inc. and Ceapro Inc. recently announced they have entered into a definitive agreement to combine operations in an all-stock merger of equals transaction…..
ReciBioPharm Partners With Acuitas Therapeutics to Provide Rapid Technology Transfers & cGMP Manufacture of LNP Formulations
ReciBioPharm, the advanced and emerging therapies business unit within Recipharm, and biotechnology firm Acuitas Therapeutics have recently announced they are taking their partnership to the next level….
Abzena Partners With ProteoNic to Offer Enhanced CHO Cell Line
Abzena, the leading end-to-end bioconjugate and complex biologics CDMO, recently announced a partnership with ProteoNic Biosciences BV to license their premium protein expression….
Coya Therapeutics & Dr. Reddy’s Laboratories Enter Development & Commercialization Agreement for ALS Treatment
Dr. Reddy’s Laboratories SA and Coya Therapeutics, Inc. recently announced they have entered into a development and license agreement for the development and commercialization of COYA 302, an investigational combination therapy for….
Biora Therapeutics Announces New Research Collaboration for the BioJet Systemic Oral Delivery Platform
Biora Therapeutics, Inc. recently announced a new research collaboration with a large pharmaceutical company for its BioJet Systemic Oral Delivery Platform. The new agreement provides funding….
ProQR Therapeutics Announces Transaction Completed for Théa to Acquire Sepofarsen & Ultevursen Ophthalmic Assets
Agreement provides ProQR with initial payment of €8M and up to €165M in earn-out payments, as well as potential double-digit royalties based on commercial sales in the US and EU….
IMIDomics & Bristol Myers Squibb Expand Long-Standing Partnership to Advance Immune-Mediated Inflammatory Disease Treatment Research & Development
IMIDomics recently announced it is expanding its strategic collaboration with Bristol Myers Squibb that extends the existing relationship between the two companies, advancing their shared commitment to….
ONK Therapeutics & NAYA Biosciences Announce Research Partnership to Advance Combination Therapy of Optimally Engineered Off-the-Shelf Natural Killer Cell Therapies & FLEX-NK Bispecific Antibodies
ONK Therapeutics and NAYA Biosciences Inc. announced they have entered into a research partnership to evaluate combination therapy consisting of ONK’s optimally engineered natural….
Colorcon Unveils Corelease - A Unified Brand for Novel Controlled-Release Formulated Systems
Ready formulated systems approach simplifies the development and manufacturing for controlled release…..
Ocean Biomedical Announces Groundbreaking Breast Cancer Research Uncovering a New Tumor Suppression Pathway for Its Proprietary Anti-Chi3L1 Antibody
Ocean Biomedical, Inc. recently announced its Scientific Co-founder, Jack A. Elias, MD, co-authored new findings in the peer-reviewed journal Immunity that detail the mechanisms behind the role of….
Oxford Biomedica Signs Agreement to Acquire ABL Europe, Consolidating Position as a Global Pure-Play CDMO
Oxford Biomedica plc recently announced it has entered into a sale and purchase agreement with TSGH SAS, a subsidiary of Institut Mérieux SA, for the acquisition of….
